Association between low dose acetylsalicylic acid (ASA) and proton pump inhibitors and risk of acute myocardial infarction or coronary death
Study identifier:D961FN00006
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Association between low dose acetylsalicylic acid (ASA) and proton pump inhibitors and risk of acute myocardial infarction or coronary heart disease death - Nested case control analyses in a cohort of first-time users of low dose ASA for secondary prevention of cerebrovascular and cardiovascular outcomes.
Medical condition
Nonfatal Myocardial infarction
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
39513
Study type
Observational
Age
50 Years - 84 Years
Date
Study Start Date: 01 Jun 2011
Primary Completion Date: 01 Dec 2011
Study Completion Date: 01 Dec 2011
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Jan 2014 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| Cases Cases with nonfatal MI or coronary death | - |
| Controls Age, sex, and calendar-year matched controls sampled from the original study cohort to be a round number of at least four times the number of cases | - |
Contacts
Investigators
Principal Investigator
Luis A Garcia Rodriguez
CEIFE (Centro Español de Investigación Farmacoepidemiológica)
